Arjun Aggarwal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Arjun Aggarwal has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Amit Amin
Cardiovascular Division, Washington University School of Medicine, St. Louis, MO, USA
1 shared publicationC. Michael Gibson
Cardiovascular Division, Washington University School of Medicine, St. Louis, MO, USA
1 shared publicationDavid Herrington
1 shared publicationDavid Kandzari
Cardiovascular Division, Washington University School of Medicine, St. Louis, MO, USA
1 shared publicationDavid Zhao
1 shared publication- Elena Deych
Division of Cardiology, Washington University in St. Louis, St. Louis MO USA
1 shared publication
Latest Publications
- Open Access
- 14 July 2026
- Published by Elsevier in SSRN Electronic Journal
Electrocardiographic artificial intelligence for prediction of pacemaker implantation after transcatheter aortic valve replacement: a retrospective multi-center study Supplementary Appendix
Background: Permanent pacemaker (PPM) implantation remains a common complication after transcatheter aortic valve replacement (TAVR). Existing clinical and imaging-based risk prediction models showing limited and inconsistent performance. We evaluated whether a pre-procedural ECG-based artificial intelligence (ECG-AI) model predicts 30-day PPM post-TAVR. Methods: In this retrospective multicenter study, a 1-dimensional convolutional neural network was trained on 34,745 ECGs from 5,932 patients with moderate-to-severe aortic stenosis (proxy cohort) to enable prediction of 30-day PPM implantation after TAVR using preprocedural ECGs. Zero-shot external validation was performed in two independent TAVR cohorts (Atrium Health Wake Forest Baptist [AHWFB] and Sanger Heart and Vascular Institute [SHVI]) without recalibration or fine-tuning. Model performance was assessed using discrimination and calibration metrics, with subgroup analyses by valve platform, clinical factors, and ECG-to-TAVR timing. Incremental and independent prognostic value was evaluated using multivariable logistic regression incorporating clinical and imaging covariates. Findings: The model was evaluated in two heterogeneous TAVR cohorts (AHWFB, n=823; SHVI, n=162) with differences in baseline characteristics and valve use, demonstrating moderate but consistent discrimination across cohorts (AHWFB: AUROC 0·67 [0·61–0·73], Brier 0·11 [0·09–0·13]; SHVI: AUROC 0·78 [0·67–0·88], Brier 0·07 [0·04–0·11]) with high negative predictive value (0·92–0·99). Performance remained stable for ECGs obtained within 0–2 days pre-TAVR (AUROC ~0·75–0·78) and in Sapien-only analyses (AHWFB: 0·77 [0·70–0·84]; SHVI: 0·79 [0·68–0·89]). In multivariable models, baseline covariates modestly improved discrimination (ΔAUC ≤0·06 in SHVI), while ECG-AI remained the only independent and consistent predictor (OR 1·36–2·18). Interpretation: An ECG-AI model trained in a large cohort demonstrated robust, transferable prediction of 30-day PPM post-TAVR using pre-procedural ECGs across multiple TAVR cohorts without recalibration. It captured prognostic information beyond traditional baseline risk factors and showed consistent independent and incremental predictive value.
- 14 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessElectrocardiographic artificial intelligence for prediction of pacemaker implantation after transcatheter aortic valve replacement: a retrospective multi-center study Supplementary Appendix
Background: Permanent pacemaker (PPM) implantation remains a common complication after transcatheter aortic valve replacement (TAVR). Existing clinical and imaging-based risk prediction models showing limited and inconsistent performance. We evaluated whether a pre-procedural ECG-based artificial intelligence (ECG-AI) model predicts 30-day PPM post-TAVR. Methods: In this retrospective multicenter study, a 1-dimensional convolutional neural network was trained on 34,745 ECGs from 5,932 patients with moderate-to-severe aortic stenosis (proxy cohort) to enable prediction of 30-day PPM implantation after TAVR using preprocedural ECGs. Zero-shot external validation was performed in two independent TAVR cohorts (Atrium Health Wake Forest Baptist [AHWFB] and Sanger Heart and Vascular Institute [SHVI]) without recalibration or fine-tuning. Model performance was assessed using discrimination and calibration metrics, with subgroup analyses by valve platform, clinical factors, and ECG-to-TAVR timing. Incremental and independent prognostic value was evaluated using multivariable logistic regression incorporating clinical and imaging covariates. Findings: The model was evaluated in two heterogeneous TAVR cohorts (AHWFB, n=823; SHVI, n=162) with differences in baseline characteristics and valve use, demonstrating moderate but consistent discrimination across cohorts (AHWFB: AUROC 0·67 [0·61–0·73], Brier 0·11 [0·09–0·13]; SHVI: AUROC 0·78 [0·67–0·88], Brier 0·07 [0·04–0·11]) with high negative predictive value (0·92–0·99). Performance remained stable for ECGs obtained within 0–2 days pre-TAVR (AUROC ~0·75–0·78) and in Sapien-only analyses (AHWFB: 0·77 [0·70–0·84]; SHVI: 0·79 [0·68–0·89]). In multivariable models, baseline covariates modestly improved discrimination (ΔAUC ≤0·06 in SHVI), while ECG-AI remained the only independent and consistent predictor (OR 1·36–2·18). Interpretation: An ECG-AI model trained in a large cohort demonstrated robust, transferable prediction of 30-day PPM post-TAVR using pre-procedural ECGs across multiple TAVR cohorts without recalibration. It captured prognostic information beyond traditional baseline risk factors and showed consistent independent and incremental predictive value.